NEM
30
2
ZION
49
9
SNA
56
3
AEP
45
5
INTC
35
4
DFS
64
4
ABBV
40
5
DIS
70
2
HRB
40
3
EQIX
59
2
AMG
33
-11
AMGN
42
14
OMC
37
2
NOV
45
2
AKAM
50
2
AAL
56
5
ED
39
8
PYPL
49
4
APA
30
5
FIS
43
5
NEM
30
2
ZION
49
9
SNA
56
3
AEP
45
5
INTC
35
4
DFS
64
4
ABBV
40
5
DIS
70
2
HRB
40
3
EQIX
59
2
AMG
33
-11
AMGN
42
14
OMC
37
2
NOV
45
2
AKAM
50
2
AAL
56
5
ED
39
8
PYPL
49
4
APA
30
5
FIS
43
5
Financhill
Back

Collegium Pharmaceutical 10K Form

Sell
33

COLL
Collegium Pharmaceutical

Last Price:
$29.16
Seasonality Move:
4.71%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-07 10Q COLL/Collegium Pharmaceutical Quarterly
2023-08-03 10Q COLL/Collegium Pharmaceutical Quarterly
2023-05-04 10Q COLL/Collegium Pharmaceutical Quarterly
2022-11-03 10Q COLL/Collegium Pharmaceutical Quarterly
2022-08-04 10Q COLL/Collegium Pharmaceutical Quarterly
2022-05-10 10Q COLL/Collegium Pharmaceutical Quarterly

Receive COLL News And Ratings

See the #1 stock for the next 7 days that we like better than COLL

COLL Financial Statistics

Sales & Book Value

Annual Sales: $566.8M
Cash Flow: $-9.2M
Price / Cash Flow: 7.09
Annual Sales: $7.27
Price / Book: 4.09

Profitability

EPS (TTM): 2.33000
Net Income (TTM): $88.6M
Gross Margin: $326.2M
Return on Equity: 42.3%
Return on Assets: 7.23%

Collegium Pharmaceutical Earnings Forecast

Key Collegium Pharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 10 years for COLL is 57.55%.
  • The Selling, General & Administrative Expenses for COLL have been equal to 28.09% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 173.06% of Operating Income.
  • The Net Earning history of COLL is 8.50% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 7 years.

Collegium Pharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: COLL
CUSIP: 19459J
Website: collegiumpharma.com

Debt

Debt-to-Equity Ratio: 3.7
Current Ratio: 0.97
Quick Ratio: 0.76

Price-to-Earnings

Trailing P/E Ratio: 23.02
Forward P/E Ratio: 4.52

COLL Technical Analysis vs Fundamental Analysis

Sell
33
Collegium Pharmaceutical (COLL) is a Sell

Is Collegium Pharmaceutical a Buy or a Sell?